Skip to main content

Advertisement

Log in

Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice

  • Regular Article
  • Published:
Cell and Tissue Research Aims and scope Submit manuscript

Abstract

We have previously developed autologous bone marrow cell infusion (ABMi) therapy for liver cirrhosis patients. One problem associated with ABMi therapy is that general anesthesia is required to obtain 400 ml bone marrow fluid from liver cirrhosis patients. However, many patients with decompensated cirrhosis do not meet the criteria, because of decreased liver function or an increased bleeding tendency. To overcome these issues, our aim is to derive liver repair cells from small amounts of autologous bone marrow aspirates obtained under local anesthesia and to use these cells in liver cirrhosis patients. Here, we conducted, by using a mouse model, basic research aimed at achieving novel liver regeneration therapy. We cultured bone marrow cells aspirated from the femurs of C57 BL/6 Tg14 (act-EGFP) OsbY01 mice (green fluoresent protein [GFP]-transgenic mice). After 14 days of culture with serum-free medium (good manufacturing practice grade), the obtained spindle-shaped GFP-positive cells were injected (1×104 cells) via the caudal vein into mice with carbon tetrachloride (CCl4)-induced cirrhosis. Numerous cultured macrophages and some mesenchymal stem cells repopulated the cirrhotic liver. The results showed that serum albumin, liver fibrosis and liver function were significantly improved in the group treated with cultured bone marrow cells (P<0.01). Moreover, matrix metalloproteinase-9 expression was increased in the liver (P<0.01). Thus, infusion of bone-marrow-derived cultured cells improved liver function and liver fibrosis in mice with CCl4-induced cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

BMC:

Bone marrow cell

GFP:

Green fluorescent protein

CCl4 :

Carbon tetrachloride

ABMi :

Autologous bone marrow cell infusion

MSC:

Mesenchymal stem cell

GMP:

Good manufacturing practice

PBS:

Phosphate-buffered saline

FITC:

Fluorescein isothiocyanate

PE:

Phycoreythrin

PI:

Propidium iodide

DAB:

Diaminobenzidine

FBS:

Fetal bovine serum

α-SMA:

α-Smooth muscle actin

MMP9:

Matrix metalloproteinase-9

References

  • Agata H, Watanabe N, Ishii Y, Kubo N, Ohshima S, Yamazaki M, Tojo A, Kagami H (2009) Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. Biochem Biophys Res Commun 382:353–358

    Article  PubMed  CAS  Google Scholar 

  • Fang LJ, Fu XB, Cheng B, Sun TZ, Li JF, Cao R, Wang YX (2004) Study on the potentiation of bone marrow mesenchymal stem cells involved in sebaceous duct formation. Zhonghua Wai Ke Za Zhi 42:1136–1138

    PubMed  Google Scholar 

  • Friedenstein AJ, Latzinik NW, Grosheva AG, Gorskaya UF (1982) Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges. Exp Hematol 10:217–227

    PubMed  CAS  Google Scholar 

  • Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S, Niioka M, Watanabe T, Okano H, Matsuzaki Y, Shiota G, Okazaki I (2007) Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 45:213–222

    Article  PubMed  CAS  Google Scholar 

  • Jin H, Yamamoto N, Uchida K, Terai S, Sakaida I (2007) Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet. Biochem Biophys Res Commun 364:801–807

    Article  PubMed  CAS  Google Scholar 

  • Kim JK, Park YN, Kim JS, Park MS, Paik YH, Seok JY et al (2010) Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant 19:1237–1246

    Article  PubMed  Google Scholar 

  • Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T, Ohgushi H, Yagi K (2006) Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 44:742–748

    Article  PubMed  CAS  Google Scholar 

  • Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ (2004) Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662–1668

    Article  PubMed  CAS  Google Scholar 

  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Article  PubMed  CAS  Google Scholar 

  • Saito T, Okumoto K, Haga H, Nishise Y, Ishii R, Sato C, Watanabe H, Okada A, Ikeda M, Togashi H, Ishikawa T, Terai S, Sakaida I, Kawata S (2011) Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev 20:1503–1510

    Article  PubMed  CAS  Google Scholar 

  • Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K (2004) Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 40:1304–1311

    Article  PubMed  Google Scholar 

  • Soleimani M, Nadri S (2009) A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 4:102–106

    Article  PubMed  CAS  Google Scholar 

  • Terai S, Sakaida I (2011) Autologous bone marrow cell infusion therapy for liver cirrhosis patients. J Hepatobiliary Pancreat Sci 18:23–25

    Article  PubMed  Google Scholar 

  • Terai S, Sakaida I, Yamamoto N, Omori K, Watanabe T, Ohata S, Katada T, Miyamoto K, Shinoda K, Nishina H, Okita K (2003) An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem (Tokyo) 134:551–558

    Article  CAS  Google Scholar 

  • Terai S, Sakaida I, Nishina H, Okita K (2005) Lesson from the GFP/CCl4 model—translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis. J Hepatobiliary Pancreat Surg 12:203–207

    Article  PubMed  Google Scholar 

  • Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I (2006) Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24:2292–2298

    Article  PubMed  CAS  Google Scholar 

  • Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, Hartland S, Ramachandran P, Van Deemter M, Hume DA, Iredale JP, Forbes SJ (2011) Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 53:2003–2015

    Article  PubMed  CAS  Google Scholar 

  • Tropel P, Noël D, Platet N, Legrand P, Benabid AL, Berger F (2004) Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 295:395–406

    Article  PubMed  CAS  Google Scholar 

  • Wu LM, Li LD, Liu H, Ning KY, Li YK (2005) Effects of Guiyuanfang and autologous transplantation of bone marrow stem cells on rats with liver fibrosis. World J Gastroenterol 11:1155–1160

    PubMed  CAS  Google Scholar 

  • Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN, Xiang P (2005) Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 11:3431–3440

    PubMed  Google Scholar 

  • Zheng JF, Liang LJ, Wu CX, Chen JS, Zhang ZS (2006) Transplantation of fetal liver epithelial progenitor cells ameliorates experimental liver fibrosis in mice. World J Gastroenterol 12:7292–7298

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to Ms. Mariko Yamada, Ms. Ihoko Fujimoto and Ms. Yoko Fukuzumi for assistance with cell culture, immunohistochemical analysis and animal care.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuji Terai.

Additional information

This study was supported by Grants-in-Aid for scientific research from the Japan Society for the Promotion of Science (no. 22390150) and the Ministry of Health, Labour and Welfare, the Japan Science and Technology Agency (JST) and the Project of Realization of Regenerative Medicine and Highway.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwamoto, T., Terai, S., Hisanaga, T. et al. Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice. Cell Tissue Res 351, 487–495 (2013). https://doi.org/10.1007/s00441-012-1528-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00441-012-1528-z

Keywords

Navigation